| 000 | 01795 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517190639.0 | ||
| 264 | 0 | _c20180702 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2017.11.033 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWen, Kuo-Chang | |
| 245 | 0 | 0 |
_aThe role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma. _h[electronic resource] |
| 260 |
_bGynecologic oncology _c02 2018 |
||
| 300 |
_a383-392 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntifibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDown-Regulation _xphysiology |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xetiology |
| 650 | 0 | 4 |
_aEpithelial Cell Adhesion Molecule _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xphysiology |
| 650 | 0 | 4 |
_aGene Silencing _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNeoplasm Transplantation _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aTranexamic Acid _xpharmacology |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 700 | 1 | _aSung, Pi-Lin | |
| 700 | 1 | _aChou, Yu-Ting | |
| 700 | 1 | _aPan, Chih-Ming | |
| 700 | 1 | _aWang, Peng-Hui | |
| 700 | 1 | _aLee, Oscar Kuang-Sheng | |
| 700 | 1 | _aWu, Cheng-Wen | |
| 773 | 0 |
_tGynecologic oncology _gvol. 148 _gno. 2 _gp. 383-392 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2017.11.033 _zAvailable from publisher's website |
| 999 |
_c27857458 _d27857458 |
||